MAPT and Alzheimer disease: Moreover, the dysfunctions of multiple AD‐related proteins, including Aβ, tau, ROCK2, CDK5, and GSK3β, can be found in the brain of APP/PS1 transgenic mice, indicating that this animal model is suitable for studying anti‐AD drugs with the action on multiple targets [33, 34].